Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07575958
Effects of Aquatic Exercise in Older Adults With Sarcopenia:A Randomized TrialGaziosmanpasa Research and Education HospitalRecruitingNot Applicable
NCT07575958Recruiting
Not Applicable
Effects of Aquatic Exercise in Older Adults With Sarcopenia:A Randomized TrialGaziosmanpasa Research an...
NCT07576439
Influence of Keratinized Tissue Width and Attached Gingiva Width on Root Coverage in Patients With Recession Defects: A Prospective Clinical StudyPostgraduate Institute of Dental Sciences RohtakNot Yet RecruitingNot Applicable
NCT07576439Not Yet Recruiting
Not Applicable
Influence of Keratinized Tissue Width and Attached Gingiva Width on Root Coverag...Postgraduate Institute of...
NCT07574853
Study on Silk Fibroin-Reinforced Collagen-Based Composite Membrane for Periodontal Bone Tissue RegenerationThe First Affiliated Hospital of Xinxiang Medical CollegeNot Yet RecruitingNot Applicable
NCT07574853Not Yet Recruiting
Not Applicable
Study on Silk Fibroin-Reinforced Collagen-Based Composite Membrane for Periodont...The First Affiliated Hosp...
NCT07574762
Total Knee Arthroplasty With Personalized Implantation: Computer Navigation-Assisted Surgery Versus Robotic-Assisted SurgeryGroupe Hospitalier Diaconesses Croix Saint-SimonRecruitingNot Applicable
NCT07574762Recruiting
Not Applicable
Total Knee Arthroplasty With Personalized Implantation: Computer Navigation-Assi...Groupe Hospitalier Diacon...
NCT07576010
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graft-versus-Host DiseaseDaihong LiuActive Not RecruitingPhase 1
NCT07576010Active Not Recruiting
Phase 1
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graf...Daihong Liu
NCT07576023
A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in Subjects With Seborrheic DermatitisPierre Fabre Dermo CosmetiqueCompletedNot Applicable
NCT07576023Completed
Not Applicable
A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in...Pierre Fabre Dermo Cosmet...
NCT07575880
Screening for Obstructive Respiratory Disorders in the General Population During the "Mai Poumon 2026" Prevention Campaign: Prevalence and Impact on the Care PathwayCentre Hospitalier de la côte BasqueNot Yet Recruiting
NCT07575880Not Yet Recruiting
—
Screening for Obstructive Respiratory Disorders in the General Population During...Centre Hospitalier de la...
NCT07576413
Effects of Standing Desks and Intermittent Walking on Cognitive FatigueClarkson UniversityCompletedNot Applicable
NCT07576413Completed
Not Applicable
Effects of Standing Desks and Intermittent Walking on Cognitive FatigueClarkson University
NCT07575412
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDSThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07575412Not Yet Recruiting
Phase 2
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDSThe First Affiliated Hosp...
NCT07576647
Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision-making (ORDERed)McMaster UniversityNot Yet RecruitingNot Applicable
NCT07576647Not Yet Recruiting
Not Applicable
Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision...McMaster University
NCT07575100
MAITLAND MOBILIZATION VERSUS THERAPEUTIC ULTRASOUND ON TRISMUS FOLLOWING THIRD MOLAR SURGERYCairo UniversityCompletedNot Applicable
NCT07575100Completed
Not Applicable
MAITLAND MOBILIZATION VERSUS THERAPEUTIC ULTRASOUND ON TRISMUS FOLLOWING THIRD M...Cairo University
NCT07576959
Effect of Bismuth Add-on to Dual Therapy for Helicobacter Pylori EradicationNational Taiwan University HospitalRecruitingPhase 3
NCT07576959Recruiting
Phase 3
Effect of Bismuth Add-on to Dual Therapy for Helicobacter Pylori EradicationNational Taiwan Universit...
NCT07576257
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension)Sahlgrenska University HospitalNot Yet RecruitingPhase 2
NCT07576257Not Yet Recruiting
Phase 2
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili...Sahlgrenska University Ho...
NCT07574645
Spinal Dural Arteriovenous Fistula International Data and Outcomes RegistryThomas Jefferson UniversityRecruiting
NCT07574645Recruiting
—
Spinal Dural Arteriovenous Fistula International Data and Outcomes RegistryThomas Jefferson Universi...
NCT07576400
Dietary Interventions in the Secondary Prevention of Myocardial Infarction: Focus on Plant-Based NutritionMasaryk UniversityCompletedNot Applicable
NCT07576400Completed
Not Applicable
Dietary Interventions in the Secondary Prevention of Myocardial Infarction: Focu...Masaryk University
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07576153
Effects of Unilateral Versus Bilateral Task Specific Training With Visual Feedback in Post Stroke PatientsRiphah International UniversityActive Not RecruitingNot Applicable
NCT07576153Active Not Recruiting
Not Applicable
Effects of Unilateral Versus Bilateral Task Specific Training With Visual Feedba...Riphah International Univ...
NCT07574489
Whole Versus Partial Gland Boost During Prostate SBRTUniversity of NebraskaNot Yet RecruitingPhase 2
NCT07574489Not Yet Recruiting
Phase 2
Whole Versus Partial Gland Boost During Prostate SBRTUniversity of Nebraska
NCT07575334
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fudan UniversityRecruitingNot Applicable
NCT07575334Recruiting
Not Applicable
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fud...
Result Breakdown
Not yet recruiting8 (40%)
Recruiting6 (30%)
Completed4 (20%)
Active, not recruiting2 (10%)
not_applicable13 (65%)
Phase 23 (15%)
Not Specified2 (10%)
Phase 11 (5%)
Phase 31 (5%)